EU Backs DiaMonTech's Portable Diabetes Device

The DiaMonTech team - © DiaMonTech
Berlin-based medtech company DiaMonTech has secured €2.5 million in funding from the European Innovation Council (EIC) Accelerator to advance its non-invasive glucose monitoring technology. According to information provided in the company's press release, the funding will support the development of a portable device that could make blood sugar monitoring easier for people living with diabetes.
DiaMonTech has spent years developing a patented technology that uses mid-infrared light to measure glucose levels through the skin, eliminating the need for regular blood sampling. The company's larger measurement system, D-Base, has already delivered promising clinical results. In a blinded clinical trial conducted at the Institute for Diabetes Technology in Ulm, the system achieved measurement accuracy comparable to early minimally invasive continuous glucose monitoring solutions.
The newly funded project focuses on D-Pocket, a compact device designed to deliver glucose readings within seconds after a user places a finger or wrist on a sensor. Over the next 18 months, DiaMonTech plans to further miniaturize key optical and electronic components and develop a working prototype.
The funding was awarded through the highly competitive EIC Accelerator program, part of Horizon Europe. According to the press release, the funding agreement was signed in September 2026 and the project officially began on October 1.
Looking ahead, DiaMonTech sees potential beyond handheld devices. The company is working toward integrating its technology into future wearables, opening new possibilities for continuous health monitoring. If successful, the Berlin startup could bring needle-free glucose measurement one step closer to everyday life.
Thinking about launching a business, setting up premises, or creating partnerships in Berlin?
We invite you to contact us.
Our team is ready to help you with our free consultation services.